Circular RNA hsa_circ_0000317 inhibits non-small cell lung cancer progression through regulating microRNA-494-3p/phosphatase and tensin homolog deleted on chromosome 10 axis
- PMID: 35917658
- PMCID: PMC9344349
- DOI: 10.1016/j.clinsp.2022.100086
Circular RNA hsa_circ_0000317 inhibits non-small cell lung cancer progression through regulating microRNA-494-3p/phosphatase and tensin homolog deleted on chromosome 10 axis
Abstract
Background: Circular RNA (circRNA), a group of non-coding RNA, is pivotal in the progression of various cancers, including Non-Small Cell Lung Cancer (NSCLC). Some circRNAs have been reported to be implicated in the progression of NSCLC, however, the function and molecular mechanism of hsa_circ_0000317 (circ_0000317) in NSCLC have not been fully understood.
Methods: The significantly differentially expressed circRNA in NSCLC tissues, circ_0000317, was screened out by microarray. Circ_0000317, microRNA(miR)-494-3p and Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) expressions in NSCLC tissues were respectively probed by quantitative real-time polymerase chain reaction and western blot assay. MTT and Transwell assays were adopted to examine the growth, migration, and invasion of NSCLC cells. Bioinformatics, luciferase reporter gene assay, RNA immunoprecipitation, and RNA pull-down assay were conducted to probe the relationships among circ_0000317, miR-494-3p, and PTEN.
Results: Circ_0000317 expression level was reduced in NSCLC tissues and cell lines. Circ_0000317 expression in NSCLC patients was associated with TNM stage and lymphatic metastasis. Circ_0000317 overexpression restrained the proliferation, migration, and invasion of NSCLC cells, but co-transfection of miR-494-3p mimics partially reversed this effect. In addition, circ_0000317, was identified as a competitive endogenous RNA, which could sponge miR-494-3p to increase PTEN expression and activate PI3K/AKT pathway.
Conclusion: Circ_0000317, inhibits NSCLC progression via modulating miR-494-3p/PTEN/PI3K/AKT pathway.
Keywords: Circ_0000317; Non-small cell lung cancer cells; PTEN; miR-494-3p.
Copyright © 2022 HCFMUSP. Published by Elsevier España, S.L.U. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflicts of interest.
Figures





Similar articles
-
Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression.Bioengineered. 2021 Dec;12(1):414-425. doi: 10.1080/21655979.2021.1872191. Bioengineered. 2021. PMID: 33467964 Free PMC article.
-
Hsa_circ_0001640 inactivation of the PI3K/AKT signaling pathway by targeting the MiR-942-5p/PTEN axis to inhibit the progression of non-small cell lung cancer.Exp Cell Res. 2025 Jul 15;450(2):114673. doi: 10.1016/j.yexcr.2025.114673. Epub 2025 Jul 12. Exp Cell Res. 2025. PMID: 40659239
-
Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p.J Bioenerg Biomembr. 2021 Apr;53(2):223-233. doi: 10.1007/s10863-021-09876-6. Epub 2021 Mar 9. J Bioenerg Biomembr. 2021. PMID: 33687619
-
A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study.Front Med (Lausanne). 2022 Oct 31;9:1027758. doi: 10.3389/fmed.2022.1027758. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36388933 Free PMC article.
-
Circular RNA_0000285: A novel double-edged sword circular RNA in human malignancies.Pathol Res Pract. 2023 Nov;251:154900. doi: 10.1016/j.prp.2023.154900. Epub 2023 Oct 20. Pathol Res Pract. 2023. PMID: 37871444 Review.
Cited by
-
Role of microRNA-494 in tumor progression.Am J Transl Res. 2023 Nov 15;15(11):6342-6361. eCollection 2023. Am J Transl Res. 2023. PMID: 38074823 Free PMC article. Review.
-
Oncogenic circ-SLC16A1 promotes progression of non-small cell lung cancer via regulation of the miR-1287-5p/profilin 2 axis.Cell Mol Biol Lett. 2024 Mar 27;29(1):43. doi: 10.1186/s11658-024-00549-x. Cell Mol Biol Lett. 2024. PMID: 38539084 Free PMC article.
-
Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer.Noncoding RNA Res. 2024 Aug 9;10:1-15. doi: 10.1016/j.ncrna.2024.08.002. eCollection 2025 Feb. Noncoding RNA Res. 2024. PMID: 39296640 Free PMC article. Review.
-
Non-coding RNAs and exosomal non-coding RNAs in lung cancer: insights into their functions.Front Cell Dev Biol. 2024 May 27;12:1397788. doi: 10.3389/fcell.2024.1397788. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38859962 Free PMC article. Review.
References
-
- Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. - PubMed
-
- Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
-
- Arbour K.C., Riely G.J. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA. 2019;322(8):764–774. - PubMed
-
- Du L., Morgensztern D. Chemotherapy for advanced-stage non-small cell lung cancer. Cancer J. 2015;21(5):366–370. - PubMed
-
- Zhou Z.Y., Xu L., Li H.G., Tian J.H., Jiao L.J., You S.F., et al. Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial. J Integr Med. 2014;12(3):175–181. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials